AI-Assisted Structured Guidance for Narrative Review Writing
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University
About this trial
This randomized, parallel-group, assessor-blinded educational study will evaluate whether one session of AI-assisted structured guidance improves the quality of narrative literature reviews written by medical postgraduate students. A total of 102 students enrolled in an academic writing course will be randomly assigned to either an AI-assisted structured guidance group or a free AI use group. Both groups may use AI tools under academic integrity requirements and will complete a narrative literature review according to the same course requirements. The guidance group will receive one structured guidance session approximately two weeks before final submission. The session will be based on the six dimensions of the Scale for the Assessment of Narrative Review Articles (SANRA). The primary outcome is the final SANRA total score of the submitted narrative literature review.
Eligibility criteria
Qualifiers
Master's students enrolled in the Academic Standards and Thesis Writing course.
Willing to participate in this study, able to understand the study procedures and randomization arrangement, and able to provide written informed consent.
Able to complete literature searching, use AI tools, and complete online questionnaires.
Disqualifiers
Students who have confirmed withdrawal from the course, suspension of study, long-term leave, or other known objective reasons that prevent participation in subsequent major teaching activities and study procedures.
Students who have participated in pilot testing, intervention material development, assessment training, or data processing related to this study.
Trial design
Treatments tested in this trial
- AI-Assisted Structured Guidance
- Free AI Use
Treatment groups
102 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov